Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of triptorelin pamoate 11.25 mg in children with precocious puberty
2005-005644-11Phase 3Completed
- Sponsor
- Ipsen
- Start
- May 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triptorelin in precocious puberty, sponsored by Ipsen. Primary endpoint: Proportion of children with suppressed LH response to GnRH at 3 months. Started May 2007; status: completed.
02
Drugs
triptorelin
03
Conditions
precocious puberty
Beyond the preview
Go deeper on 2005-005644-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005644-11.